Kaili Zhong

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.

Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.

Journal: Blood cancer discovery
Published: April 10, 2026

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Journal: Annals of hematology
Published: February 03, 2026

BATF in CD8 + T cells from patients with myelodysplastic syndromes.

BATF in CD8 + T cells from patients with myelodysplastic syndromes.

Journal: Journal of cancer research and therapeutics
Published: October 10, 2025

Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy.

Effects and mechanisms of Helicobacter pylori on cancers development and immunotherapy.

Journal: Frontiers in immunology
Published: July 23, 2024

First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.

First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.

Journal: BMC cancer
Published: November 15, 2022

Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor Prognosis of Diffuse Large B-cell Lymphoma.

Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor Prognosis of Diffuse Large B-cell Lymphoma.

Journal: Discovery medicine
Published: October 24, 2022

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.

Journal: Aging
Published: January 30, 2021

Murine myeloid dendritic cells that phagocytose apoptotic T cells inhibit the immune response via NO.

Murine myeloid dendritic cells that phagocytose apoptotic T cells inhibit the immune response via NO.

Journal: PloS one
Published: May 25, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026